Mycophenolate mofetil during Pregnancy: Some words of caution

Pediatrics

Volumn 122, Issue 1, 2008, Pages 184-185

  Vento, Maximo ^a   Aytes, Antonio Perez ^a   Ledo, Ana ^a   Boso, Virginia ^b   Carey, John C ^c  

^a HOSPITAL INFANTIL LA FE   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ABERRANT BLOOD VESSEL; ANOTIA; AUTOIMMUNE DISEASE; BRACHYDACTYLY; CLEFT LIP; CLEFT PALATE; COLOBOMA; CONGENITAL HEART DISEASE; CORPUS COLLOSUM AGENESIS; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG WITHDRAWAL; ECHOGRAPHY; ECTOPIC KIDNEY; EMBRYOTOXICITY; EXTERNAL AUDITORY CONDUCT ATRESIA; FETUS HYDROPS; FETUS MALFORMATION; GESTATIONAL AGE; GRAFT RECIPIENT; HUMAN; HYPERTELORISM; HYPOPLASTIC FINGERNAIL; HYPOPLASTIC TOENAIL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROGNATHIA; MICROTIA; NAIL HYPOPLASIA; NONHUMAN; NOTE; ORGAN TRANSPLANTATION; PHENOTYPE; POLYDACTYLY; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SHORTENED FINGER; SYNDACTYLY; SYSTEMIC LUPUS ERYTHEMATOSUS; TERATOGENICITY; ARTICLE; CONGENITAL MALFORMATION; DRUG EFFECT; FEMALE; FETUS; PREGNANCY COMPLICATION;

ABNORMALITIES, DRUG-INDUCED; FEMALE; FETUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; ORGAN TRANSPLANTATION; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 48249111386     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-0348     Document Type: Note

References (15)

1. McKay DB, Josephson MA. Pregnancy in recipients of solid organs: effects on mother and child. N Engl J Med. 2006; 354(12):1281-1293
2. Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005;353(21):2219-2228
3. Gaubitz M, Schorat A, Schotte H, Kern P, Domschke W. My-cophenolate mofetil for the treatment of systemic lupus erythematosus: an open pilot trial. Lupus. 1999;8(9):731-736
4. Tendron A, Gouyon JB, Decramer S. In utero exposure to immunosuppressive drugs: experimental and clinical studies. Pediatr Nephrol. 2002;17(2):121-130
5. Perez-Aytes A, Ledo A, Boso V, et al. In utero exposure to mycophenolate mofetil: a characteristic phenotype? Am J Med Genet A. 2008;146(1):1-7
6. US Food and Drug Administration. MedWatch. Accessed at: www.fda.gov/medwatch. Accessed January 31, 2008
7. Pergola PE, Kancharla A, Riley DJ. Kidney transplantation during the first trimester of pregnancy: immunosuppression with mycophenolate mofetil, tacrolimus, and prednisone. Transplantation. 2001;71(7):994-997
8. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil orsirolimus. Transplantation. 2006;82(12):1698-1702
9. Velinov M, Zellers N. The fetal mycophenolate mofetil syndrome. Clin Dysmorphol. 2008;17(1):77-78
10. CellCept1 [package insert]. Nutley, NJ: Roche Pharmaceuticals;1998
11. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004:103-114
12. Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol. 2004;103(5 pt 2):1091-1094
13. Tjeertes IF, Bastiaans DE, van Ganzewinkel CJ, Zegers SH. Neonatal anemia and hydrops fetalis after maternal mycophe-nolate mofetil use. J Perinatol. 2007;27(1):62-64
14. El Sebaaly Z, Charpentier B, Snanoudj R. Fetal malformations associated with mycophenolate mofetil for lupus nephritis. Nephrol Dial Transplant. 2007;22(9):2722
15. Schoner K, Steinhard J, Figiel J, Rehder H. Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil? Obstet Gynecol. 2008;111(2 pt 2):483-486